Bradley K Taylor Selected Research

Bradley K Taylor Research Topics

Disease

35	Pain (Aches) 02/2024 - 08/2003
27	Hyperalgesia 07/2023 - 06/2002
23	Hypersensitivity (Allergy) 12/2023 - 06/2002
17	Neuralgia (Stump Neuralgia) 12/2023 - 03/2004
12	Chronic Pain 11/2021 - 02/2007
9	Inflammation (Inflammations) 01/2022 - 04/2002
7	Cold Hypersensitivity 12/2023 - 09/2007
7	Postoperative Pain 08/2023 - 02/2014
6	Peripheral Nerve Injuries 11/2023 - 03/2004
3	Multiple Sclerosis 01/2018 - 05/2015
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 05/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2023 - 12/2009
2	Surgical Wound 08/2023 - 11/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 01/2017
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 03/2016
2	Ataxia (Dyssynergia) 05/2015 - 12/2009
2	Edema (Dropsy) 06/2004 - 06/2002
1	Myalgia 01/2021
1	Pruritus (Itching) 01/2020

Drug/Important Bio-Agent (IBA)

13	Analgesics (Analgesic Drugs)IBA 02/2024 - 03/2004
13	Neuropeptide YIBA 02/2024 - 04/2002
9	Opioid Receptors (Opioid Receptor)IBA 12/2023 - 01/2014
7	Opioid Analgesics (Opioids)IBA 08/2023 - 06/2004
5	LigandsIBA 01/2021 - 07/2008
5	PPAR gammaIBA 01/2021 - 06/2002
4	Naltrexone (ReVia)FDA LinkGeneric 01/2022 - 04/2015
4	salicylhydroxamic acid (SHAM)IBA 01/2022 - 07/2012
4	CarrageenanIBA 01/2021 - 06/2002
4	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 04/2020 - 04/2012
4	CalciumIBA 01/2019 - 07/2012
4	Formaldehyde (Formol)FDA Link 01/2018 - 02/2004
4	Naloxone (Narcan)FDA LinkGeneric 11/2016 - 01/2013
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2021 - 03/2016
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 01/2014
3	Adenylyl Cyclases (Adenylyl Cyclase)IBA 04/2020 - 01/2014
3	BIBO 3304IBA 04/2020 - 04/2002
3	Pioglitazone (Actos)FDA Link 01/2019 - 03/2015
3	Pyruvaldehyde (Methylglyoxal)IBA 01/2019 - 03/2016
3	EnzymesIBA 01/2019 - 01/2007
3	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2019 - 01/2015
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2015 - 06/2002
2	Narcotic Antagonists (Opioid Antagonists)IBA 01/2022 - 01/2013
2	phenylalanyl- cyclo(cysteinyltyrosyl- tryptophyl- ornithyl- threonyl- penicillamine)threoninamide (CTOP)IBA 01/2022 - 01/2020
2	AticaprantIBA 11/2021 - 01/2020
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2021 - 01/2020
2	5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanolIBA 11/2021 - 01/2019
2	erythromycin propionate-N-acetylcysteinateIBA 11/2021 - 01/2019
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2019
2	SaporinsIBA 01/2021 - 10/2019
2	NeurotoxinsIBA 01/2021 - 10/2019
2	AcetoneIBA 01/2018 - 09/2007
2	Antidepressive Agents (Antidepressants)IBA 01/2018 - 01/2017
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 09/2007
2	Protein Isoforms (Isoforms)IBA 01/2017 - 12/2009
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 02/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 03/2004
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2015 - 04/2009
2	Freund's AdjuvantIBA 10/2014 - 09/2004
2	Ranolazine FDA Link 10/2014 - 12/2009
2	Voltage-Gated Sodium ChannelsIBA 10/2014 - 12/2009
2	Morphine (MS Contin)FDA LinkGeneric 03/2011 - 06/2004
2	PPAR alphaIBA 04/2009 - 06/2002
2	Rosiglitazone (Avandia)FDA Link 07/2008 - 06/2002
2	Substance PIBA 09/2004 - 03/2004
1	clozapine N-oxideIBA 12/2023
1	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 11/2023
1	resiniferatoxinIBA 10/2023
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 07/2023
1	Blood Alcohol ContentIBA 07/2023
1	pyrazoleIBA 07/2023
1	Ethanol (Ethyl Alcohol)IBA 07/2023
1	Calcitonin Gene-Related PeptideIBA 01/2023
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022
1	SphingolipidsIBA 01/2022
1	Ondansetron (Zofran)FDA LinkGeneric 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Cyclic AMP (AMP, Cyclic)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	3- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA 11/2021
1	Dizocilpine Maleate (Dizocilpine)IBA 11/2021
1	15-deoxyprostaglandin J2IBA 01/2021
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2021
1	ProstaglandinsIBA 01/2021
1	NeuropeptidesIBA 01/2021
1	TRPA1 Cation ChannelIBA 04/2020
1	naltrindoleIBA 01/2020
1	norbinaltorphimineIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 03/2019
1	propionic acid (potassium propionate)IBA 01/2019
1	AnkyrinsIBA 01/2019

Therapy/Procedure

9	Analgesia 08/2023 - 06/2004
3	Spinal Injections 01/2022 - 02/2014
3	Drug Therapy (Chemotherapy) 11/2021 - 03/2016
2	Ligation 09/2007 - 03/2004
1	Therapeutics 01/2019